Key figures for 2016: More than 3.3 million people are receiving medication for diabetes in France, representing 5% of the population. Among those receiving medication for diabetes: 244...

The "One Health" approach to combating antibiotic resistance, promoted by the World Health Organization since 2015, encourages the integration of prevention efforts across human health,...

Introduction: The purpose of this article is to summarize the current understanding of tobacco use in France based on representative population surveys.Current state of knowledge:...

The surveillance of healthcare-associated infections (HAIs) is a priority in intensive care, a high-risk setting due to patients’ critical condition and their exposure to invasive...

Introduction: Since 2002, hepatitis E surveillance has been coordinated by the National Reference Center (CNR) for Enteric Hepatitis Viruses (hepatitis A and E). In recent years,...

Introduction: The Asbestos Victims Compensation Fund (FIVA) was established in 2002 to supplement the occupational disease system and enable all asbestos victims—including self-employed...

Controlling the spread of multidrug-resistant bacteria (MDRB) in healthcare facilities is a priority of the national program for the prevention of healthcare-associated infections...

Since 1996, national prevalence surveys (NPS) of healthcare-associated infections (HAIs) and antimicrobial treatments (AMT) have been conducted approximately every five years. The 2015...

Data from the Program for the Medicalization of Information Systems in Medicine, Surgery, Obstetrics, and Dentistry (PMS I-MCO) for the years 2009 through 2014 were analyzed to quantify...

Introduction: Chikungunya and dengue are two arboviral diseases transmitted primarily by Aedes albopictus, a mosquito species present in mainland France since 2004. In 2006, they were...